I have designed a clinical trial and hope you can help me predict whether this trial can pass Phase I.
The following is my clinical trial:

disease: ['tumors']
drugs: ['dasatinib + ketoconazole']
phase: 1
criteria: 
        Inclusion Criteria:

          -  ECOG status 0-2

          -  Advanced or metastatic disease, unresponsive to standard treatment (or no standard
             treatment exists)

          -  Biopsy pretreatment

          -  Adequate bone marrow, liver and kidney function

        Exclusion Criteria:

          -  Serious cardiovascular disease

          -  Bleeding disorders

          -  Gastrointestinal (GI) tract disease

          -  Platelet inhibitors

          -  H2 blockers, proton pump inhibitors
